A Quality Improvement Project to Increase Pharmacist-Initiated Methicillin Resistant Staphylococcus Aureus Nasal Swab PCR for Vancomycin De-Escalation in Pediatric Patients With Respiratory Tract Infections
The Journal of Pediatric Pharmacology and Therapeutics · 2026-06 · 31 (3) · 413-418
DOI: 10.5863/jppt-25-00080 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pediatric Pharmacology and Therapeutics, 2026-06. Verfasst von Kimberly James und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy (KJ), UF Health Shands Hospital, Gainesville, FL. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE Overuse of broad-spectrum empiric antimicrobials remains common in children hospitalized with respiratory tract infections (RTI). A negative methicillin-resistant Staphylococcus aureus (MRSA) nasal swab (MNS) polymerase chain reaction (PCR) result has been shown to have a high negative predictive value for MRSA in RTI. In this quality improvement (QI) initiative, we developed a pharmacist-driven approach to reduce the duration of empiric vancomycin for RTI in children. The primary aim was the time to de-escalation of vancomycin, and the secondary aim was the reduction in vancomycin monitoring in patients hospitalized with RTI. METHODS Baseline duration of vancomycin therapy was assessed by conducting a retrospective chart review. After root cause analysis and engaging key stakeholders, an electronic health record OurPractice Advisory (OPA) was implemented, prompting pharmacists to order an MNS PCR during order verification for vancomycin with an RTI indication. RESULTS Preimplementation (01/01/2021 to 08/31/2023) included 89 patients, and 25 postimplementation (09/21/2023 to 05/31/2024). We found a 36% decrease in mean vancomycin duration from 53 to 34 hours after implementation of the pharmacist-driven OPA. Postimplementation, 24% of patients had a vancomycin concentration obtained, compared with 37% preimplementation. No patients were readmitted within 30 days postimplementation, compared with 1 patient preimplementation. CONCLUSIONS This QI initiative provides preliminary data that empiric vancomycin duration in pediatric patients with RTI may be impacted by pharmacist-facing OPA implementation, prompting ordering of MNS PCR at the time of vancomycin verification. This initiative could be replicated at other institutions seeking to reduce empiric vancomycin usage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy (KJ), UF Health Shands Hospital, Gainesville, FL.
- Department of Pharmacy (TP), OhioHealth Grant Medical Center, Columbus, OH.
- Department of Pharmacy (KJ), Mayo Clinic Health System, Austin, MN.
- Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine (NR), Mayo Clinic, Rochester, MN.
- Department of Pharmacy (JH, GL, BA, LD), Mayo Clinic, Rochester, MN.
Zitieren
APA
James, K., Patel, T., Jensen, K., Rajapakse, N., Heyliger, J., Lee, G., Anderson, B., & Dinnes, L. (2026). A Quality Improvement Project to Increase Pharmacist-Initiated Methicillin Resistant Staphylococcus Aureus Nasal Swab PCR for Vancomycin De-Escalation in Pediatric Patients With Respiratory Tract Infections. The Journal of Pediatric Pharmacology and Therapeutics, 31(3), 413-418. https://doi.org/10.5863/jppt-25-00080
Vancouver
James K, Patel T, Jensen K, Rajapakse N, Heyliger J, Lee G, et al. A Quality Improvement Project to Increase Pharmacist-Initiated Methicillin Resistant Staphylococcus Aureus Nasal Swab PCR for Vancomycin De-Escalation in Pediatric Patients With Respiratory Tract Infections. The Journal of Pediatric Pharmacology and Therapeutics. 2026;31(3):413-418. doi:10.5863/jppt-25-00080
BibTeX
@article{James2026,
author = {James, Kimberly and Patel, Trinkal and Jensen, Kelsey and Rajapakse, Nipunie and Heyliger, Jamie and Lee, Grace and Anderson, Ben and Dinnes, Laura},
title = {A Quality Improvement Project to Increase Pharmacist-Initiated Methicillin Resistant Staphylococcus Aureus Nasal Swab PCR for Vancomycin De-Escalation in Pediatric Patients With Respiratory Tract Infections},
journal = {The Journal of Pediatric Pharmacology and Therapeutics},
year = {2026},
volume = {31},
number = {3},
pages = {413--418},
doi = {10.5863/jppt-25-00080}
}
EUVIMED